查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604728

心房顫動市場：按產品、設備和最終用戶分類 - 全球預測 2025-2030

Atrial Fibrillation Market by Product (Access Devices, Cardiac Monitors or Implantable Loop Recorder, EP Ablation Catheters), Device (Non-Surgical Devices, Surgical Devices), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心房顫動市場價值為94.6億美元，預計到2024年將達到107.5億美元，複合年成長率為13.71%，到2030年將達到232.8億美元。

心房顫動（心房顫動）是一種常見的心律不整，其特徵是心率不規則且通常較快，會增加中風、心臟衰竭和其他心臟併發症的風險。鑑於人口老化和全球心血管疾病盛行率不斷上升，心房顫動相關產品和服務（包括藥物、醫療設備和診斷工具）的市場範圍廣泛。心房顫動與高發病率和醫療費用有關，這一事實凸顯了對有效心房顫動管理的需求，促進了先進治療方法和技術的開發和應用。最終用戶（主要是醫院、診斷中心和專科診所）始終需要創新的解決方案來有效診斷、管理和監測心房顫動。影響市場的主要成長要素包括穿戴式裝置的技術進步、微創手術的增加以及研發方面的大力投資。潛在的商機在於遠端醫療領域的快速成長，其中人工智慧和機器學習的整合用於預測分析和決策支援以及遠端監控功能。然而，與心房顫動治療相關的限制，例如高成本、監管挑戰和抗心律不整藥物的潛在副作用，對市場成長構成了主要障礙。此外，各地區缺乏標準化通訊協定使治療和管理策略更加複雜。存在創新途徑，包括開發個人化醫療方法、探索個人化治療方法的基因和生物標記以及增強患者教育工具以提高依從性和結果。心房顫動市場是一個充滿活力的市場，其特點是技術快速採用和激烈競爭。相關人員必須專注於策略聯盟、監管合規和持續創新，以充分利用新工具的潛力並有效解決未滿足的需求。專注於非侵入性診斷選擇和生活方式介入是開拓開拓領域並在這一不斷變化的環境中提供競爭優勢的絕佳機會。

主要市場統計
基準年[2023] 94.6億美元
預測年份 [2024] 107.5億美元
預測年份 [2030] 232.8億美元
複合年成長率（%） 13.71%

市場動態：揭示快速發展的心房顫動市場的關鍵市場洞察

供需的動態交互作用正在改變心房顫動市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 老年族群中心心房顫動的盛行率上升
    • 政府和全球衛生組織改善心房顫動治療的策略
    • 心律不整治療中越來越偏好心導管電氣燒灼術
  • 市場限制因素
    • 治療成本上升和熟練專家的短缺
  • 市場機會
    • 心房顫動治療和診斷的技術進展
    • 心房顫動藥物和治療獲得有利核准
  • 市場挑戰
    • 對心房顫動病理生理學的理解不完全

波特五力：駕馭心房顫動市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心房顫動市場的外部影響

外部宏觀環境因素在塑造心房顫動市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心房顫動市場的競爭格局

對心房顫動市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣心房顫動市場供應商的績效評估

FPNV定位矩陣是評估心房顫動市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了心房顫動市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對心房顫動市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年族群中心心房顫動的盛行率上升
      • 各國政府和世界衛生組織的治療改善策略
      • 心導管電氣燒灼術在心律不整治療中越來越受歡迎
    • 抑制因素
      • 治療成本上升和熟練專家的短缺
    • 機會
      • 心房顫動治療和診斷方法的技術進步
      • 心房顫動藥物和治療的核准
    • 任務
      • 對 AF 病理病理學了解甚少
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心房顫動市場：依產品

  • 存取裝置
  • 心臟監測儀或植入式循環記錄儀
  • 電生理消融導管
  • EP診斷導管
  • 心內超音波心臟檢查
  • 左心耳封堵器
  • 測繪和記錄系統

第7章心房顫動市場：依設備分類

  • 非手術器械
    • 存取裝置
    • 先進的診斷導管
    • 心臟監測儀
    • 常規診斷導管
      • 固定診斷導管
      • 可操縱診斷導管
    • 診斷導管
    • 電去心房顫動
    • 心內超音波心動圖（ICE）系統
    • 左心耳及封堵器
    • 測繪和記錄系統
  • 手術設備
    • 心導管電氣燒灼術
    • 冷凍療法
    • 雷射心導管電氣燒灼術
    • 迷路手術
    • 微波心導管電氣燒灼術
    • 用於導航的海拔測繪配件
    • 射頻心導管電氣燒灼術
      • 傳統射頻消融導管
      • 沖洗尖端射頻消融導管

第8章心房顫動市場：依最終用戶分類

  • 心臟病學
  • 肌肉骨骼

第9章 美洲心房顫動市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太心房顫動市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的心房顫動市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Acesion Pharma ApS
  • AFreeze GmbH
  • AtriCure, Inc.
  • AuriGen Medical
  • BIOTRONIK SE & CO. KG
  • Carima, Inc.
  • CathRx Ltd
  • GE Healthcare
  • Japan Lifeline Co
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Osypka AG
  • Siemens Healthcare GmbH
  • St. Jude Medical, Inc.
  • Vanguard AG
Product Code: MRR-437517DB6DD5

The Atrial Fibrillation Market was valued at USD 9.46 billion in 2023, expected to reach USD 10.75 billion in 2024, and is projected to grow at a CAGR of 13.71%, to USD 23.28 billion by 2030.

Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by an irregular and often rapid heartbeat, which can increase the risk of stroke, heart failure, and other cardiac complications. The market for AF-related products and services, including medication, medical devices, and diagnostic tools, encompasses a broad scope given the aging population and increasing prevalence of cardiovascular conditions globally. The necessity for efficient AF management is underscored by its association with high morbidity and healthcare costs, prompting the development and application of advanced therapies and technologies. End-users, primarily hospitals, diagnostic centers, and specialty clinics, are consistently in need of innovative solutions for effective diagnosis, management, and monitoring of AF. Key growth factors influencing the market include technological advancements in wearable devices, an uptick in minimally invasive surgeries, and robust investment in research and development. Potential opportunities lie in the integration of artificial intelligence and machine learning for predictive analytics and decision-making support, as well as the burgeoning telemedicine sector driven by remote monitoring capabilities. However, limitations such as high costs associated with AF treatments, regulatory challenges, and potential side effects of antiarrhythmic drugs pose significant barriers to market growth. Additionally, a lack of standardized protocols across regions further complicates treatment and management strategies. Innovative avenues exist in the development of personalized medicine approaches, exploring genetic and biomarkers for individualized treatment regimens, and enhancing patient education tools to improve adherence and outcomes. The AF market is dynamic, characterized by rapid technological adoption and increasing competition. Stakeholders must focus on strategic collaborations, regulatory compliance, and continuous innovation to leverage the full potential of emerging tools and address the unmet needs effectively. Enhanced focus on non-invasive diagnostic options and lifestyle interventions represents an untapped area ripe for exploration and offers a competitive edge in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 9.46 billion
Estimated Year [2024] USD 10.75 billion
Forecast Year [2030] USD 23.28 billion
CAGR (%) 13.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Atrial Fibrillation Market

The Atrial Fibrillation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of atrial fibrillation in geriatric population
    • Government and global health organizations' strategies to improve atrial fibrillation treatment
    • Increasing preference of catheter ablation for cardiac arrhythmia treatment
  • Market Restraints
    • High price of treatment and dearth of skilled professionals
  • Market Opportunities
    • Technology advancements in treatment and diagnostic methods to atrial fibrillation
    • Favorable approvals for atrial fibrillation drugs and treatment
  • Market Challenges
    • Incomplete understanding of the pathophysiology of AF

Porter's Five Forces: A Strategic Tool for Navigating the Atrial Fibrillation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Atrial Fibrillation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Atrial Fibrillation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Atrial Fibrillation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Atrial Fibrillation Market

A detailed market share analysis in the Atrial Fibrillation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Atrial Fibrillation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Atrial Fibrillation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Atrial Fibrillation Market

A strategic analysis of the Atrial Fibrillation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, AFreeze GmbH, AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Carima, Inc., CathRx Ltd, GE Healthcare, Japan Lifeline Co, Johnson & Johnson Services, Inc., Koninklijke Philips N.V, Medtronic PLC, Osypka AG, Siemens Healthcare GmbH, St. Jude Medical, Inc., and Vanguard AG.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Access Devices, Cardiac Monitors or Implantable Loop Recorder, EP Ablation Catheters, EP Diagnostic Catheter, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, and Mapping & Recording Systems.
  • Based on Device, market is studied across Non-Surgical Devices and Surgical Devices. The Non-Surgical Devices is further studied across Access Devices, Advanced Diagnostic Catheters, Cardiac Monitors, Conventional Diagnostic Catheters, Diagnostic Catheters, Electric Cardioversion, Intracardiac Echocardiography (ICE) Systems, Left Atrial Appendage & Closure Devices, and Mapping & Recording Systems. The Conventional Diagnostic Catheters is further studied across Fixed Diagnostic Catheters and Steerable Diagnostic Catheters. The Surgical Devices is further studied across Catheter Ablation, Cryoablation, Laser-Based Catheter Ablation, Maze Surgery, Microwave-Based Catheter Ablation, Navigational Advanced Mapping Accessories, and Radiofrequency Catheter Ablation. The Radiofrequency Catheter Ablation is further studied across Conventional RF Ablation Catheters and Irrigated-tip RF Ablation Catheters.
  • Based on End-User, market is studied across Cardiology and Musculoskeletal.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of atrial fibrillation in geriatric population
      • 5.1.1.2. Government and global health organizations' strategies to improve atrial fibrillation treatment
      • 5.1.1.3. Increasing preference of catheter ablation for cardiac arrhythmia treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High price of treatment and dearth of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Technology advancements in treatment and diagnostic methods to atrial fibrillation
      • 5.1.3.2. Favorable approvals for atrial fibrillation drugs and treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Incomplete understanding of the pathophysiology of AF
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Atrial Fibrillation Market, by Product

  • 6.1. Introduction
  • 6.2. Access Devices
  • 6.3. Cardiac Monitors or Implantable Loop Recorder
  • 6.4. EP Ablation Catheters
  • 6.5. EP Diagnostic Catheter
  • 6.6. Intracardiac Echocardiography
  • 6.7. Left Atrial Appendage Closure Devices
  • 6.8. Mapping & Recording Systems

7. Atrial Fibrillation Market, by Device

  • 7.1. Introduction
  • 7.2. Non-Surgical Devices
    • 7.2.1. Access Devices
    • 7.2.2. Advanced Diagnostic Catheters
    • 7.2.3. Cardiac Monitors
    • 7.2.4. Conventional Diagnostic Catheters
      • 7.2.4.1. Fixed Diagnostic Catheters
      • 7.2.4.2. Steerable Diagnostic Catheters
    • 7.2.5. Diagnostic Catheters
    • 7.2.6. Electric Cardioversion
    • 7.2.7. Intracardiac Echocardiography (ICE) Systems
    • 7.2.8. Left Atrial Appendage & Closure Devices
    • 7.2.9. Mapping & Recording Systems
  • 7.3. Surgical Devices
    • 7.3.1. Catheter Ablation
    • 7.3.2. Cryoablation
    • 7.3.3. Laser-Based Catheter Ablation
    • 7.3.4. Maze Surgery
    • 7.3.5. Microwave-Based Catheter Ablation
    • 7.3.6. Navigational Advanced Mapping Accessories
    • 7.3.7. Radiofrequency Catheter Ablation
      • 7.3.7.1. Conventional RF Ablation Catheters
      • 7.3.7.2. Irrigated-tip RF Ablation Catheters

8. Atrial Fibrillation Market, by End-User

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Musculoskeletal

9. Americas Atrial Fibrillation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Atrial Fibrillation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Atrial Fibrillation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acesion Pharma ApS
  • 3. AFreeze GmbH
  • 4. AtriCure, Inc.
  • 5. AuriGen Medical
  • 6. BIOTRONIK SE & CO. KG
  • 7. Carima, Inc.
  • 8. CathRx Ltd
  • 9. GE Healthcare
  • 10. Japan Lifeline Co
  • 11. Johnson & Johnson Services, Inc.
  • 12. Koninklijke Philips N.V
  • 13. Medtronic PLC
  • 14. Osypka AG
  • 15. Siemens Healthcare GmbH
  • 16. St. Jude Medical, Inc.
  • 17. Vanguard AG

LIST OF FIGURES

  • FIGURE 1. ATRIAL FIBRILLATION MARKET RESEARCH PROCESS
  • FIGURE 2. ATRIAL FIBRILLATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ATRIAL FIBRILLATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ATRIAL FIBRILLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ATRIAL FIBRILLATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ATRIAL FIBRILLATION MARKET DYNAMICS
  • TABLE 7. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS OR IMPLANTABLE LOOP RECORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP DIAGNOSTIC CATHETER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING & RECORDING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ADVANCED DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY FIXED DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY STEERABLE DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ELECTRIC CARDIOVERSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE & CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING & RECORDING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CATHETER ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LASER-BASED CATHETER ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAZE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MICROWAVE-BASED CATHETER ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NAVIGATIONAL ADVANCED MAPPING ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL RF ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY IRRIGATED-TIP RF ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 166. TAIWAN ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 173. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 180. VIETNAM ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 195. DENMARK ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 202. EGYPT ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 209. FINLAND ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 216. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 223. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 230. ISRAEL ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 237. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 244. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 251. NIGERIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 257. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 258. NORWAY ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 265. POLAND ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 272. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 278. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 279. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 285. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 286. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 299. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 300. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 306. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 307. SWEDEN ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 313. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 314. SWITZERLAND ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 320. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2030 (USD MILLION)
  • TABLE 321. TURKEY ATRIAL FIBRILLATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED ARAB EMIRATES ATRIAL FIB